Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: A prospective cohort study with 2 years of follow-up

Cerebrovascular Diseases

Volumn 35, Issue 5, 2013, Pages 469-475

  Sun, Wen ^a,b   Yuan, Cuiping ^b,c   Liu, Wenhua ^a,b   Li, Yongkun ^a   Huang, Zhixin ^a,b   Zhu, Wusheng ^a,b   Li, Min ^a,b   Xu, Gelin ^a,b   Liu, Xinfeng ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Anterior choroidal artery; Cerebral microbleeds; Deep and periventricular white matter; Intraventricular hemorrhage; Moyamoya disease; Posterior communicating artery

Indexed keywords

ADULT; ANGIOGRAPHY; ARTICLE; BRAIN ARTERY; BRAIN HEMORRHAGE; DEEP AND PERIVENTRICULAR WHITE MATTER; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRACRANIAL ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUSCEPTIBILITY WEIGHTED IMAGING; WHITE MATTER; AGE; AGED; ANTERIOR CHOROIDAL AND POSTERIOR COMMUNICATING ARTERY; BASAL GANGLION; BRAIN HEMATOMA; BRAIN INFARCTION; BRAIN ISCHEMIA; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL LOBE; POSTERIOR COMMUNICATING ARTERY; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

ADULT; ANGIOGRAPHY, DIGITAL SUBTRACTION; ASYMPTOMATIC DISEASES; CEREBRAL HEMORRHAGE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

ANTITHROMBOCYTIC AGENT;

EID: 84878351449     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000350203     Document Type: Article

References (37)

1. Scott R, Smith E: Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360: 1226-1237
2. Rim N, Kim H, Shin Y, Kim S: Which CT perfusion parameter best reflects cerebrovascular reserve? Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients. AJNR Am J Neuroradiol 2008; 29: 1658-1663
3. Taki W, Yonekawa Y, Kobayashi A, Ishikawa M, Kikuchi H, Nishizawa S, Yonekura Y, Tanada S, Fukuyama H: Cerebral circulation and metabolism in adults' moyamoya disease- PET study. Acta Neurochir (Wien) 1989; 100: 150-154
4. So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, Kang E, Lee DS: Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke 2005; 36: 1485-1489
5. Kawaguchi S, Okuno S, Sakaki T: Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 2000; 93: 397-401
6. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA, Breteler MM: Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol 2009; 8: 165-174
7. Sueda Y, Naka H, Ohtsuki T, Kono T, Aoki S, Ohshita T, Nomura E, Wakabayashi S, Kohriyama T, Matsumoto M: Positional relationship between recurrent intracerebral hemorrhage/ lacunar infarction and previously detected microbleeds. AJNR Am J Neuroradiol 2010; 31: 1498-1503
8. Bokura H, Saika R, Yamaguchi T, Nagai A, Oguro H, Kobayashi S, Yamaguchi S: Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke 2011; 42: 1867-1871
9. Okazaki S, Sakaguchi M, Hyun B, Nagano K, Tagaya M, Sakata Y, Sakaguchi T, Kitagawa K: Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis. Cerebrovasc Dis 2011; 32: 483-488
10. Ishikawa T, Kuroda S, Nakayama N, Terae S, Kudou K, Iwasaki Y: Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir (Tokyo) 2005; 45: 495-500
11. Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, Miki Y, Fushmi Y, Yamamoto A, Yamada K, Fukuyama H, Hashimoto N: Asymptomatic microbleeds in moyamoya disease: T2. -weighted gradient-echo magnetic resonance imaging study. J Neurosurg 2005; 102: 470-475
12. Kikuta K, Takagi Y, Nozaki K, Sawamoto N, Fukuyama H, Hashimoto N: The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery 2008; 62: 104-111
13. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoyaacute; disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99(suppl 2):S238-S240
14. Liu W, Zhu S, Wang X, Yue X, Zhou Z, Wang H, Xu G, Zhou C, Liu X: Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease. J Clin Neurosci 2011; 18: 374-378
15. Suzuki J, Takaku A: Cerebrovascular 'moyamoyaacute;disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969: 20: 288-299
16. Mugikura S, Takahashi S, Higano S, Shirane R, Kurihara N, Furuta S, Ezura M, Takahashi A: The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR Am J Neuroradiol 1999; 20: 336-343
17. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, Werring DJ: The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. Neurology 2009; 73: 1759-1766
18. Liu X, Xu G, Wu W, Zhang R, Yin Q, Zhu W: Subtypes and one-year survival of first-ever stroke in Chinese patients: The Nanjing Stroke Registry. Cerebrovasc Dis 2006; 22: 130-136
19. Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, Zong R, Han C, Zhao F, Feng J: Moyamoya disease in China: Its clinical features and outcomes. Stroke 2012; 43: 56-60
20. Liu X, Zhang D, Shuo W, Zhao Y, Wang R, Zhao J: Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 2013; 84: 258-265
21. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, Huang QJ, Lou ZX: Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 2010; 112: 199-203
22. Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, Song D, Zhang J, Guan M, Gu Y: Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One 2012; 7:e48179
23. Hung CC, Tu YK, Su CF, Lin LS, Shih CJ: Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosurg 1997; 99(suppl 2):S23-S25
24. Lin R, Xie Z, Zhang J, Xu H, Su H, Tan X, Tian D, Su M: Clinical and immunopathological features of Moyamoya disease. PLoS One 2012; 7:e36386
25. Hoshino H, Izawa Y, Suzuki N, Research Committee on Moyamoya Disease: Epid emiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo) 2012; 52: 295-298
26. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: Findings from a nationwide epidemiological survey. Stroke 2008; 39: 42-47
27. Mori N, Miki Y, Kikuta K, Fushimi Y, Okada T, Urayama S, Sawamoto N, Fukuyama H, Hashimoto N, Togashi K: Microbleeds in moy amoya disease: Susceptibility-weighted imag ing versus T2 . -weighted imaging at 3 Tesla. Invest Radiol 2008; 43: 574-579
28. Horie N, Morikawa M, Nozaki A, Hayashi K, Suyama K, Nagata I: 'Brush sign' on susceptibility- weighted MR imaging indicates the severity of moyamoya disease. AJNR Am J Neuroradiol 2011; 32: 1697-1702
29. Cordonnier C, Al-Shahi Salman R, Wardlaw J: Spontaneous brain microbleeds: Systematic review, subgroup analyses and standards for study design and reporting. Brain 2007; 130: 1988-2003
30. Shoamanesh A, Kwok CS, Benavente O: Cerebral microbleeds: Histopathological correlation of neuroimaging. Cerebrovasc Dis 2011; 32: 528-534
31. van Es AC, van der Grond J, de Craen AJ, Admiraal- Behloul F, Blauw GJ, van Buchem M: Risk factors for cerebral microbleeds in the elderly. Cerebrovasc Dis 2008; 26: 397-403
32. Gorelick PB: Cerebral microbleeds: Evidence of heightened risk associated with aspirin use. Arch Neurol 2009; 66: 691-693
33. Zhou ZM, Yang S, Yue XY, Zhu WS, Ma MM, Xu GL, Liu XF: Influencing factors for cerebral microbleeds in patients with acute ischemic stroke. Zhonghua Yi Xue Za Zhi 2010; 90: 451-453
34. Yamashita M, Oka K, Tanaka K: Histopathology of the brain vascular network in moyamoya disease. Stroke 1983; 14: 50-58
35. Atlas SW, Mark AS, Grossman RI, Gomori JM: Intracranial hemorrhage: Gradient-echo MR imaging at 1.5 T. Comparison with spinecho imaging and clinical applications. Radiology 1988; 168: 803-807
36. Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, Ushio Y: Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 2003; 34: 90-95
37. Fisher CM: Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971; 30: 536-550